Atlas FDA

Juvederm Injectable Gel Implants

FDA premarket approval P050047/S075 · decided 2020-05-27

Approval details

PMA number
P050047
Supplement
S075
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Juvederm Injectable Gel Implants
Generic name
Implant, dermal, for aesthetic use
Applicant
Allergan
Date received
2020-04-24
Decision date
2020-05-27
Days to decision
33 days
Decision code
OK30
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Irvine, CA
Statement
Change to the cleaning process of manufacturing equipment used during the manufacturing of Juvéderm injectable gel products.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
NATRELLE INSPIRA Single Use Sizers for Gel Implants (K203229)Allergan2021-06-02
TrueTear Intranasal Tear Neurostimulator (K193589)Allergan2020-08-31
Natrelle 133 Plus MICROCELL Tissue Expander (K180826)Allergan2018-12-21
Natrelle 133S Tissue Expander (K182054)Allergan2018-08-29
TrueTear Intranasal Tear Neurostimulator (DEN170086)Allergan2018-05-17
SERI SURGICAL SCAFFOLD (K123128)Allergan2013-04-25